AI assistant
DEXCOM INC — Director's Dealing 2024
May 24, 2024
30198_dirs_2024-05-24_5a3bb5a1-2488-46eb-9d43-9d6f32035686.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2024-05-22
Reporting Person: Driscoll Rimma (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-22 | Common Stock | A | 2632 | $0.0 | Acquired | 6640 | Direct |
Footnotes
F1: The RSU Award was granted on May 22, 2024 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2025 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F2: Represents 6,640 restricted stock units, of which 2,632 were granted on May 22, 2024 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting and 4,008 that were granted on August 24, 2023 and will vest over three years until August 24, 2026.